Wall Street brokerages predict that CIGNA Co. (NYSE:CI) will report $3.45 earnings per share (EPS) for the current fiscal quarter, Zacks reports. Eight analysts have provided estimates for CIGNA’s earnings, with the lowest EPS estimate coming in at $3.27 and the highest estimate coming in at $3.56. CIGNA reported earnings per share of $2.83 in the same quarter last year, which would suggest a positive year over year growth rate of 21.9%. The business is scheduled to report its next quarterly earnings results before the market opens on Thursday, November 1st.

On average, analysts expect that CIGNA will report full year earnings of $13.87 per share for the current year, with EPS estimates ranging from $13.74 to $14.00. For the next year, analysts forecast that the firm will post earnings of $15.72 per share, with EPS estimates ranging from $14.41 to $21.59. Zacks’ earnings per share calculations are an average based on a survey of research analysts that that provide coverage for CIGNA.

CIGNA (NYSE:CI) last posted its earnings results on Thursday, August 2nd. The health services provider reported $3.89 earnings per share for the quarter, beating the consensus estimate of $3.33 by $0.56. The firm had revenue of $11.50 billion during the quarter, compared to analyst estimates of $11.20 billion. CIGNA had a net margin of 5.82% and a return on equity of 22.27%. The business’s quarterly revenue was up 10.9% on a year-over-year basis. During the same period in the previous year, the firm earned $2.91 EPS.

Several equities research analysts recently commented on the stock. SunTrust Banks boosted their price target on shares of CIGNA and gave the stock a “buy” rating in a report on Thursday, September 27th. Zacks Investment Research lowered shares of CIGNA from a “strong-buy” rating to a “hold” rating in a report on Tuesday, October 9th. Leerink Swann boosted their price target on shares of CIGNA from $235.00 to $250.00 and gave the stock an “outperform” rating in a report on Friday, September 21st. Credit Suisse Group boosted their price target on shares of CIGNA from $223.00 to $237.00 and gave the stock an “outperform” rating in a report on Tuesday, September 18th. Finally, Cantor Fitzgerald assumed coverage on shares of CIGNA in a report on Wednesday, September 26th. They issued an “overweight” rating and a $245.00 price target for the company. Three research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. CIGNA has a consensus rating of “Buy” and an average target price of $231.14.

Shares of NYSE:CI traded down $0.76 during trading on Wednesday, hitting $211.20. 89,737 shares of the stock traded hands, compared to its average volume of 2,349,681. The company has a debt-to-equity ratio of 0.35, a current ratio of 0.38 and a quick ratio of 0.38. The firm has a market cap of $50.68 billion, a price-to-earnings ratio of 20.17, a price-to-earnings-growth ratio of 1.23 and a beta of 0.64. CIGNA has a 52-week low of $163.02 and a 52-week high of $227.13.

In other CIGNA news, CFO Eric P. Palmer bought 2,828 shares of the stock in a transaction on Tuesday, July 31st. The shares were bought at an average price of $177.61 per share, with a total value of $502,281.08. Following the purchase, the chief financial officer now directly owns 9,678 shares in the company, valued at approximately $1,718,909.58. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director William D. Zollars sold 238 shares of CIGNA stock in a transaction on Friday, September 14th. The stock was sold at an average price of $193.70, for a total transaction of $46,100.60. The disclosure for this sale can be found here. Insiders own 1.10% of the company’s stock.

A number of institutional investors and hedge funds have recently made changes to their positions in the business. Pennsylvania Trust Co increased its stake in CIGNA by 1.2% during the third quarter. Pennsylvania Trust Co now owns 20,363 shares of the health services provider’s stock worth $4,241,000 after purchasing an additional 245 shares during the period. Huntington National Bank increased its stake in CIGNA by 22.2% during the second quarter. Huntington National Bank now owns 1,617 shares of the health services provider’s stock worth $275,000 after purchasing an additional 294 shares during the period. Boston Financial Mangement LLC increased its stake in CIGNA by 15.8% during the second quarter. Boston Financial Mangement LLC now owns 2,315 shares of the health services provider’s stock worth $393,000 after purchasing an additional 315 shares during the period. Burney Co. increased its stake in CIGNA by 1.5% during the second quarter. Burney Co. now owns 21,718 shares of the health services provider’s stock worth $3,691,000 after purchasing an additional 318 shares during the period. Finally, Mutual of America Capital Management LLC increased its stake in CIGNA by 1.1% during the second quarter. Mutual of America Capital Management LLC now owns 31,390 shares of the health services provider’s stock worth $5,335,000 after purchasing an additional 334 shares during the period. 89.42% of the stock is currently owned by institutional investors.

CIGNA Company Profile

Cigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. It operates through Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations segments. The Global Health Care segment offers medical, dental, behavioral health, vision, and prescription drug benefit plans, as well as health advocacy programs, and other products and services to insured and self-insured customers.

Read More: Why do company’s buyback their stock?

Get a free copy of the Zacks research report on CIGNA (CI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for CIGNA (NYSE:CI)

Receive News & Ratings for CIGNA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CIGNA and related companies with MarketBeat.com's FREE daily email newsletter.